Dr. Jarrod P Holmes, M.D.
Claim this profileProvidence Medical Group
Studies Breast Cancer
Studies Leukemia
5 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
metastatic
2Leukemia
Affiliated Hospitals
Clinical Trials Jarrod P Holmes, M.D. is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
More about Jarrod P Holmes, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jarrod P Holmes, M.D. has experience with
- Enobosarm
- Exemestane
- Sabizabulin
- Pirtobrutinib
- Venetoclax
- Rituximab
Breakdown of trials Jarrod P Holmes, M.D. has run
Breast Cancer
Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jarrod P Holmes, M.D. specialize in?
Jarrod P Holmes, M.D. focuses on Breast Cancer and Leukemia. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Jarrod P Holmes, M.D. currently recruiting for clinical trials?
Yes, Jarrod P Holmes, M.D. is currently recruiting for 3 clinical trials in Santa Rosa California. If you're interested in participating, you should apply.
Are there any treatments that Jarrod P Holmes, M.D. has studied deeply?
Yes, Jarrod P Holmes, M.D. has studied treatments such as Enobosarm, Exemestane, Sabizabulin.
What is the best way to schedule an appointment with Jarrod P Holmes, M.D.?
Apply for one of the trials that Jarrod P Holmes, M.D. is conducting.
What is the office address of Jarrod P Holmes, M.D.?
The office of Jarrod P Holmes, M.D. is located at: Providence Medical Group, Santa Rosa, California 95043 United States. This is the address for their practice at the Providence Medical Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.